We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Throughout the year, you will have the opportunity to participate in campaigns that support endocrinology research, care, professionals, and patients. Contact us to get more involved: [email protected].
The Endocrine Society is urging Congress to help researchers recover from the COVID-19 pandemic, restart their labs, and continue making progress on important research progress that was interrupted by the pandemic. The most promising vehicle for providing research relief through additional funds is the Research Investment to Spark the Economy (RISE) Act, which was introduced last year and has bipartisan support. The RISE Act would authorize approximately $25 billion in additional funds for research recovery, including nearly $10 billion for the NIH. While the bill has significant bipartisan support – they need more cosponsors to ensure that the Act makes it across the finish line!
Take action in our campaign and tell your Representative support the RISE Act so that our research community can recover from pandemic-related closures and other disruptions. Advocacy matters and if the research community is vocal about their needs, we can ensure that increased federal funds for research are consistent and sustainable.
The Endocrine Society is urging Congress to provide $46.1 billion for the National Institutes of Health (NIH) in fiscal year (FY) 2022, an increase of $3.2 billion over FY 2021. Currently, the Congress is beginning to consider funding decisions for FY 2022, so it is critical to let Representatives and Senators know our funding requests now.
Last year, we helped secure a $1.25 billion increase for NIH, continuing a six-year trend of increases to the NIH budget. We are proud of our victories and what they mean for the endocrine research community. If we have learned anything from our past efforts, it is that advocacy matters and that if the research community is vocal about their needs, we can ensure that increased federal funds for research are consistent and sustainable.
It is critical that all members of Congress hear from YOU, their constituents, about the need to provide robust, sustained, and timely funding for NIH in FY 2022 before the end of the fiscal year.
Our advocacy calendar provides a global overview of upcoming legislative and regulatory deadlines and events.
Read our newsletters covering the latest science-based information on endocrine-disrupting chemicals (EDCs) for policymakers in the European Union.